- Home
- HCWB vs BIYA Comparison
HCWB vs BIYA Comparison
Compare HCWB & BIYA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HCWB
- BIYA
- Stock Information
- Founded
- HCWB 2018
- BIYA 2017
- Country
- HCWB United States
- BIYA China
- Employees
- HCWB N/A
- BIYA N/A
- Industry
- HCWB Biotechnology: Pharmaceutical Preparations
- BIYA
- Sector
- HCWB Health Care
- BIYA
- Exchange
- HCWB Nasdaq
- BIYA NYSE
- Market Cap
- HCWB 10.8M
- BIYA 7.8M
- IPO Year
- HCWB 2021
- BIYA 2025
- Fundamental
- Price
- HCWB $4.30
- BIYA $0.76
- Analyst Decision
- HCWB Strong Buy
- BIYA
- Analyst Count
- HCWB 1
- BIYA 0
- Target Price
- HCWB $35.00
- BIYA N/A
- AVG Volume (30 Days)
- HCWB 116.1K
- BIYA 539.3K
- Earning Date
- HCWB 08-13-2025
- BIYA 05-13-2025
- Dividend Yield
- HCWB N/A
- BIYA N/A
- EPS Growth
- HCWB N/A
- BIYA N/A
- EPS
- HCWB N/A
- BIYA N/A
- Revenue
- HCWB $1,445,145.00
- BIYA $12,809,211.00
- Revenue This Year
- HCWB $178.36
- BIYA N/A
- Revenue Next Year
- HCWB N/A
- BIYA N/A
- P/E Ratio
- HCWB N/A
- BIYA N/A
- Revenue Growth
- HCWB N/A
- BIYA 10.66
- 52 Week Low
- HCWB $3.55
- BIYA $0.59
- 52 Week High
- HCWB $100.80
- BIYA $8.00
- Technical
- Relative Strength Index (RSI)
- HCWB 42.79
- BIYA N/A
- Support Level
- HCWB $4.02
- BIYA N/A
- Resistance Level
- HCWB $4.44
- BIYA N/A
- Average True Range (ATR)
- HCWB 0.31
- BIYA 0.00
- MACD
- HCWB 0.08
- BIYA 0.00
- Stochastic Oscillator
- HCWB 31.85
- BIYA 0.00
About HCWB HCW Biologics Inc.
HCW Biologics Inc is a clinical-stage biopharmaceutical company focused on discovering and developing novel immunotherapies to lengthen the health span by disrupting the link between chronic, low-grade inflammation and age-related diseases. The company has developed TOBI discovery platform, or Tissue factor-based fusion discovery platform, for the design of category-defining immunotherapeutic drugs. It has selected two molecules as its product candidate; HCW9218 and HCW9302. HCW9218 is a bifunctional immunotherapeutic designed with the capabilities to neutralize transforming growth and stimulate immune cells. HCW9302 is designed to activate and expand regulatory T cells, which deactivate inflammasomes.
About BIYA BAIYA INTERNATIONAL GROUP INC
Baiya International Group Inc is a company which operates through its subsidiary Gongwuyuan operates a cloud-based internet platform to provide one-stop crowdsourcing recruitment and SaaS-enabled HR solutions in the flexible employment marketplace. The Company's business is focused around on four primary services which are job matching services, entrusted recruitment services, project outsourcing services and abor dispatching services in the flexible employment market within China, mainly in the core manufacturing regions including the Pearl River Delta and Yangtze River Delta region.